Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma.

RATIONALE Asthmatic airways have an increased number and size of vascular structures, which contribute to airflow obstruction and hyperresponsiveness. OBJECTIVES We examined whether proangiogenic mediators are elevated in bronchoalveolar lavage fluid (BALF) from subjects with asthma and if this translated to induction of angiogenesis. METHODS Angiogenic activity in BALF from 12 healthy, nonatopic subjects and 10 atopic subjects with mild asthma was evaluated by examining tubule formation at 11 days in cocultures of human endothelial cells with dermal fibroblasts. Vascular structures were visualized by anti-CD31 labeling and quantified by image analysis. Angiogenic growth factors in BALF from healthy subjects and subjects with asthma were identified using antibody arrays and by ELISA. MEASUREMENTS AND MAIN RESULTS Angiogenic activity induced by BALF from healthy subjects was not different from basal tubule formation (p>0.05). However, induction of tubular structures by asthmatic BALF was 2.5-fold greater (p<0.001) compared with healthy samples. Similarly, levels of proangiogenic growth factors (angiogenin, vascular endothelial growth factor [VEGF], monocyte chemotactic protein-1) were increased approximately 2.5-fold (p<0.05) in BALF from subjects with asthma, whereas antiangiogenic factors (endostatin, Ang-2) were unchanged. A blocking anti-VEGF antibody abolished tubule formation induced by BALF from either healthy subjects or subjects with asthma (p<0.01). Immunodepletion of VEGF had no effect on basal tubule formation induced by healthy BALF but abrogated enhanced tubule formation by asthmatic BALF (p<0.01). CONCLUSIONS BALF collected from subjects with asthma but not healthy subjects is functionally active in promoting angiogenesis in vitro. The proangiogenic capacity of BALF from subjects with asthma resides in elevated VEGF derived from asthmatic airways. This observation supports VEGF as a key factor in vascular remodeling in asthma.

[1]  V. Bours,et al.  Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. , 2007, Biochemical and biophysical research communications.

[2]  H. Kanazawa,et al.  Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD , 2007, Respiratory research.

[3]  R. Murphy,et al.  Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling. , 2006, Current molecular medicine.

[4]  E. Walters,et al.  Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma , 2006, Thorax.

[5]  K. Kostikas,et al.  Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe? , 2006, Respiratory research.

[6]  E. Walters,et al.  Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. , 2006, American journal of respiratory and critical care medicine.

[7]  B. O'connor,et al.  Pro-Angiogenic Activity is Increased in Bronchoalveolar Lavage Fluid (BALf) from Asthmatics , 2006 .

[8]  Salwa Bakr,et al.  A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. , 2006, Chest.

[9]  A. Foresi,et al.  Vascular endothelial growth factor up‐regulation and bronchial wall remodelling in asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  D. Robinson,et al.  Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity1 , 2005, The Journal of Immunology.

[11]  W. Stetler-Stevenson,et al.  TIMP-2: an endogenous inhibitor of angiogenesis. , 2005, Trends in molecular medicine.

[12]  T. Matsuda,et al.  Multiple β1 Integrins Mediate Enhancement of Human Airway Smooth Muscle Cytokine Secretion by Fibronectin and Type I Collagen1 , 2005, The Journal of Immunology.

[13]  Kyung Hee Hong,et al.  Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. , 2005, Blood.

[14]  G. Hu,et al.  Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis , 2005, Oncogene.

[15]  R. Homer,et al.  Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung , 2004, Nature Medicine.

[16]  Denys N. Wheatley,et al.  An in vitro model of angiogenesis: Basic features , 2004, Angiogenesis.

[17]  C. Lewis,et al.  Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo , 2004, Angiogenesis.

[18]  M. Shibuya,et al.  Induction of tube formation by angiopoietin‐1 in endothelial cell/fibroblast co‐culture is dependent on endogenous VEGF , 2003, Cancer science.

[19]  P. Wingfield,et al.  TIMP-2 Mediated Inhibition of Angiogenesis An MMP-Independent Mechanism , 2003, Cell.

[20]  K. Hirata,et al.  Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  S. Holgate,et al.  Airway remodeling in asthma: new insights. , 2003, The Journal of allergy and clinical immunology.

[22]  K. Hirata,et al.  Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. , 2002, The Journal of allergy and clinical immunology.

[23]  K. Hirata,et al.  Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients , 2002, Thorax.

[24]  Q. Hamid,et al.  Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. , 2001, The Journal of allergy and clinical immunology.

[25]  Yong Chul Lee,et al.  Vascular endothelial growth factor in patients with acute asthma. , 2001, The Journal of allergy and clinical immunology.

[26]  N. Aoike,et al.  Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.

[27]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[28]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[29]  C. D’Angio,et al.  Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. , 1997, American journal of respiratory cell and molecular biology.

[30]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[31]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[32]  A. Foresi,et al.  Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. , 1996, American journal of respiratory and critical care medicine.

[33]  J. Bousquet,et al.  Airways remodelling in asthma: no doubt, no more? , 1995, International archives of allergy and immunology.

[34]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[35]  P. Polverini,et al.  The pathophysiology of angiogenesis. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[36]  E. R. Mcfadden,et al.  Hypothesis: exercise-induced asthma as a vascular phenomenon , 1990, The Lancet.

[37]  P. Paré,et al.  The effect of submucosal edema on airways resistance. , 2015, The American review of respiratory disease.

[38]  A. Woolcock,et al.  Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.

[39]  J. Anderson,et al.  A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema , 1969, Thorax.